Ali Derakhshani Selected Research

Eyelid Diseases

1/2022

The Efficacy of Kohl (Surma) and Erythromycin in Treatment of Blepharitis: An Open-Label Clinical Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ali Derakhshani Research Topics

Disease

1	Blepharitis 01/2022
1	Eyelid Diseases 01/2022
1	COVID-19 10/2021
1	Wounds and Injuries (Trauma) 04/2019
1	Skin Ulcer 01/2018
1	Adenocarcinoma 07/2014
1	Carcinogenesis 07/2014

Drug/Important Bio-Agent (IBA)

1	lead sulfide (kohl)IBA 01/2022
1	Erythromycin (Erycette)FDA LinkGeneric 01/2022
1	Blood Group Antigens (Blood Groups)IBA 10/2021
1	AntibodiesIBA 10/2021
1	FibrinIBA 04/2019
1	Tumor Biomarkers (Tumor Markers)IBA 07/2014

Therapy/Procedure

1	Traditional Medicine (Folk Remedies) 01/2022
1	Aftercare (After-Treatment) 04/2019
1	Artificial Skin 01/2018
1	Therapeutics 07/2014